Graphique du cours de l'action 06978.HK
IMMUNOTECH-B (06978.HK)
Immunotech Biopharm Ltd
HK$2.28
-24.5%
$-0.74
Marché fermé: Apr 28, 16:00:00 HKT
Retour
Immunotech Biopharm Ltd (06978.HK)
Statistiques clés
Clôture préc.
$3.11
Prix d'ouverture
$3.02
Plage de la journée
$2.1 - $3.03
Plage de 52 semaines
$2.28 - $5.83
Volume
4.6M
Volume moyen
381.9K
Rendement en dividend
--
BPA (TTM)
-0.45
Capitalisation boursière
$1.4B
Qu’est-ce que IMMUNOTECH-B ?
Immunotech Biopharm Ltd. is an investment holding company, which through its subsidiaries engages in research and development, manufacturing and commercialization of immune cell products for treatments of cancers in the PRC. The company is headquartered in Beijing, Beijing and currently employs 173 full-time employees. The company went IPO on 2020-07-10. The firm's non-genetically modified cell product pipeline includes Expanded Activated Lymphocytes (EAL) and 6B11-OCIK Injection. The firm's chimeric antigen receptor T (CAR-T) cell product pipeline includes CAR-T-19 Injection, Denocabtagene Ciloleucel Injection and aT19 Injection. The firm's T cell receptor engineered T cell therapy (TCR-T) cell product pipeline includes YT003, YT008 and YT007. The firm mainly conducts its businesses in the domestic market.
Fonctionnalités
Ressources
© 2026 Finture Development Limited. Tous droits réservés.
